Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives-Reference-Cited by-同舟云学术

Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives

Published:2021-06 Issue: Volume:97 Page:102207
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Larroquette Mathieu^ORCID,Peyraud Florent^ORCID,Domblides Charlotte^ORCID,Lefort Félix,Bernhard Jean-Christophe,Ravaud Alain,Gross-Goupil Marine

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference71 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Survival Rates for Kidney Cancer; n.d. https://www.cancer.org/cancer/kidney-cancer/detection-diagnosis-staging/survival-rates.html [accessed April 27, 2020].

3. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease;Janzen;Urol Clin North Am,2003

4. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system;Lam;J Urol,2005

5. Systemic Therapy for Metastatic Renal-Cell Carcinoma;Choueiri;N Engl J Med,2017

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC11A1 promotes kidney renal clear cell carcinoma (KIRC) progression by remodeling the tumor microenvironment;Toxicology and Applied Pharmacology;2024-06

2. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling;Journal of Translational Medicine;2024-05-21

3. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients;BMC Genomics;2024-04-26

4. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level;Cancer Biology & Therapy;2024-04-24

5. Tumor Supplying Artery Injection of Liposome@Sunitinib Could Effectively Inhibit the Progression of Kidney Tumor;ACS Applied Materials & Interfaces;2024-04-16